The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
ERS Genomics
Dublin, Ireland
A
1-10 Employees
2014
Key takeaway
ERS Genomics is a key player in CRISPR gene editing, offering worldwide access to the essential CRISPR/Cas9 patent portfolio, which is crucial for this transformative technology.
Reference
Core business
CRISPR/Cas9 Gene Editing & Patent Licensing | ERS Genomics
ERS Genomics is the global leader in providing access to foundational patents covering CRISPR/Cas9 intellectual property and licencing.
COBO Technologies - Quality Control Genome Editing
Copenhagen, Denmark
A
1-10 Employees
2017
Key takeaway
COBO Technologies specializes in quality control for CRISPR-modified cells and animals, offering services and products that enhance the precision and reproducibility of gene editing through their INDEL Profiling Platform. With a strong focus on gene therapy and genome editing, the company leverages its expertise and innovative software to support projects related to CRISPR technology.
Reference
Core business
COBO Technologies - Quality Control Genome Editing
COBO Technologies specialised in products and services for Quality Control of CRISPR modified cells/animals. DNA mutation analysis and Protein Expression profiling
CRISPR AgroBio News (CARBON)
Copenhagen, Denmark
A
1-10 Employees
2022
Key takeaway
Biomedrex Genetics is dedicated to advancing innovation in gene therapy and genome editing, particularly through CRISPR technology. They provide comprehensive coverage of CRISPR-related topics, including safety, clinical trials, and best practices, while also exploring other genome-editing tools.
Reference
Core business
Company: Biomedrex Genetics
More than 100 companies to follow in 2023 working with a gene editing tool like CRISPR, TALEN, ZFN, Prime Editor, Base Editor, MegaNuclease...
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
CRISPR Therapeutics
Cambridge, United States
B
101-250 Employees
2013
Key takeaway
The company is a pioneer in CRISPR technology, emphasizing its commitment to developing CRISPR-based therapies that could transform medicine for future generations. Their focus on advanced gene editing and the establishment of a state-of-the-art manufacturing facility underscores their dedication to translating CRISPR/Cas9 discoveries into potential therapeutics.
Reference
Core business
News | CRISPR
Ubigene Biosciences
New York, United States
B
51-100 Employees
-
Key takeaway
Ubigene is dedicated to making genome editing easier, with a focus on providing advanced gene-editing services and products. Their innovative CRISPR-U™ technology, an improvement on CRISPR/Cas9, significantly enhances gene-editing efficiency, making it a valuable resource for researchers in the field.
Reference
Service
| Ubigene
Edilytics
Cambridge, United States
B
1-10 Employees
2019
Key takeaway
Edilytics offers advanced precision genome editing solutions, highlighting CRISPResso2 as a reliable tool for analyzing CRISPR gene editing experiments. With its user-friendly and adaptable features, researchers can access comprehensive data to support their post-processing needs.
Reference
Core business
Edilytics | Precision Genome Editing Analysis
Emendo Biotherapeutics
New York, United States
B
11-50 Employees
2015
Key takeaway
EmendoBio is dedicated to advancing CRISPR gene editing by developing innovative solutions that enhance traditional methods, aiming to effectively address complex genetic diseases. Their approach focuses on understanding genetic disorders and creating customized nucleases to unlock the full potential of CRISPR in therapeutic applications.
Reference
Core business
EmendoBio | Home | Unlocking the true potential of CRISPR
EmendoBio is boldly evolving traditional CRISPR solutions to make a positive impact on human health and previously incurable diseases.
Aldevron
Fargo, United States
B
101-250 Employees
1998
Key takeaway
Aldevron specializes in gene editing, providing custom-manufactured CRISPR-associated nucleases and Cas9 products that are engineered for various applications. Their expertise in high-quality plasmid DNA and proteins supports groundbreaking science in therapeutic and vaccine development.
Reference
Product
CRISPR Cas9 Products | Aldevron
Aldevron offers gene editing Cas9 nucleases in defined formulations as well as custom-manufactured products to meet your specific needs. Our enzymes are engineered to be used in a variety of applications including electroporation, transfection and microinjection.
GeneCopoeia
Rockville, United States
B
11-50 Employees
2000
Key takeaway
GeneCopoeia offers a range of CRISPR products and services, including sgRNA clones, which are essential for gene editing applications. Their commitment to quality is highlighted by the full sequencing of all ORF clones and related viral particles.
Reference
Product
CRISPR Products and Services, sgRNA clone, AAV | Genecopoeia
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene is focused on developing a leading therapeutic genome editing platform, highlighting their expertise and valuable intellectual property in the field, which aligns with advancements in CRISPR gene editing. Their commitment to bringing cures to patients underscores their dedication to innovative therapies.
Reference
Core business
TARGETGENE – DEVELOPING THE WORLD’S BEST THERAPEUTIC GENOME EDITING PLATFORM
Technologies which have been searched by others and may be interesting for you:
CRISPR gene editing is a revolutionary technology that allows scientists to modify an organism's DNA with precision. It utilizes a natural defense mechanism found in bacteria to target specific sequences in the genome, enabling the addition, removal, or alteration of genetic material. This approach is facilitated by two key components: the guide RNA, which directs the Cas9 enzyme to the precise location in the DNA, and the Cas9 enzyme, which acts as molecular scissors to cut the DNA at the targeted site. With its ability to make targeted changes efficiently, CRISPR has vast applications in various fields, including medicine, agriculture, and biological research. By enabling researchers to edit genes associated with diseases or enhance crop resilience, CRISPR technology holds promise for advancing genetic research and developing innovative therapies.
CRISPR gene editing operates through a system derived from the natural defense mechanisms of bacteria. It utilizes a guide RNA to direct a Cas9 enzyme to a specific location in the DNA sequence of a target organism. Once the Cas9 enzyme is accurately positioned, it introduces a double-strand break in the DNA. This break activates the cell's repair mechanisms, which can be harnessed to insert, delete, or modify specific DNA sequences. By providing a template during the repair process, researchers can effectively change the genetic code at the desired location. The precision and efficiency of this method have made CRISPR a revolutionary tool in genetic research, biotechnology, and potential therapeutic applications.
CRISPR gene editing has transformative applications across various fields. In medicine, it holds the potential for treating genetic disorders by targeting and correcting faulty genes. For instance, researchers are exploring its use in conditions such as cystic fibrosis and sickle cell anemia, aiming for precise genetic modifications to alleviate symptoms. In agriculture, CRISPR technology enhances crop resilience and productivity. By editing plant genomes, scientists can develop varieties that withstand pests, diseases, and environmental stresses. Additionally, CRISPR allows for the improvement of nutritional content in crops, contributing to food security and sustainability. The versatility of CRISPR gene editing continues to expand, offering innovative solutions to complex challenges in healthcare and agriculture.
The ethical concerns surrounding CRISPR gene editing primarily focus on issues of safety, consent, and the potential for unintended consequences. One major concern is the possibility of off-target effects, where unintended parts of the genome may be altered, leading to unforeseen health issues. Additionally, the idea of modifying human embryos raises questions about consent, as future generations cannot provide input on the changes made to their genetic makeup. Another significant issue is the potential for "designer babies," where genetic enhancements could create inequality based on access to technology. This could result in a societal divide between those who can afford genetic modifications and those who cannot. Furthermore, there are concerns about the long-term ecological impacts of editing genes in organisms, which could disrupt ecosystems and biodiversity. As the technology advances, ongoing dialogue about its ethical implications is essential to ensure responsible use.
The potential risks associated with CRISPR gene editing include unintended genetic modifications, often referred to as off-target effects. These can result in changes to other parts of the genome, potentially leading to harmful mutations. Additionally, there are concerns about the long-term consequences of gene editing, as the effects may not be immediately apparent and could result in unforeseen health issues or ecological impacts if applied in agriculture. Ethical implications also pose a significant risk, particularly in human gene editing. There are debates regarding consent, especially in germline editing, where changes can be passed down to future generations. This raises questions about the potential for designer babies and the societal ramifications of such technologies. Overall, while CRISPR holds great promise, careful consideration of these risks is essential in its application.
Some interesting numbers and facts about your company results for CRISPR Gene Editing
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 7369 |
| Amount of suitable service providers | 6422 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1998 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for CRISPR Gene Editing
What are related technologies to CRISPR Gene Editing?
Based on our calculations related technologies to CRISPR Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of CRISPR Gene Editing?
Start-Ups who are working in CRISPR Gene Editing are CRISPR AgroBio News (CARBON)
Which industries are mostly working on CRISPR Gene Editing?
The most represented industries which are working in CRISPR Gene Editing are Biotechnology, IT, Software and Services, Other, Pharmaceuticals, Medical
How does ensun find these CRISPR Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
